All Stories

  1. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  2. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  3. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  4. Elderberry-Based Multifunctional Prebiotic Systems Prepared via Spray Drying
  5. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  6. GBD 2023 Cardiovascular Disease Collaborators
  7. Octenidine Dihydrochloride – Antimicrobial Activity, Adaptation and Clinical Application
  8. Baicalein-Loaded Chitosan Films for Local Treatment of Oral Infections
  9. Identification and characterization of anaerobic bacteria in human semen: A retrospective study
  10. Polymorphic Variants of Selected Genes Regulating Bile Acid Homeostasis in Women with Intrahepatic Cholestasis of Pregnancy
  11. Health-promoting and medicinal properties of Zingiberaceae family plants: A minireview with a special focus on galangal, turmeric, cardamom, and ginger
  12. Nano-Hydroxyapatite-Based Mouthwash for Comprehensive Oral Care: Activity Against Bacterial and Fungal Pathogens with Antioxidant and Anti-Inflammatory Action
  13. Influence of bismuth selenide nanoparticles on cell mitochondrial activity: implications for cancer therapy
  14. Viral associations with hematologic cancers
  15. The therapeutic potential of Shiitake Mushrooms (Lentinula edodes)
  16. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  17. Enhancing human gut health: Global innovations in dysbiosis management
  18. Plant Alkaloids as Promising Anticancer Compounds with Blood–Brain Barrier Penetration in the Treatment of Glioblastoma: In Vitro and In Vivo Models
  19. Astaxanthin demonstrates moderate or weak activity against bacterial and fungal pathogens
  20. Azithromycin-Loaded Nanoparticles Incorporated in Chitosan-Based Soft Hydrogels: A Novel Approach for Dental Drug Delivery
  21. Activity of Antiseptics Against Pseudomonas aeruginosa and Its Adaptation Potential
  22. Exploring nutritional supplement use for countering respiratory tract infections through an X (formerly Twitter)-based survey
  23. Anticholinesterase Activity and Bioactive Compound Profiling of Six Hop (Humulus lupulus L.) Varieties
  24. The Importance of Gene Variants Related to Folate Uptake and Distribution in the Etiology of Recurrent Miscarriage and Intrauterine Fetal Demise
  25. Ginger: a total-scale analysis of the scientific literature on a widely used spice and phytotherapeutic
  26. 3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract
  27. Adaptation to Sodium Hypochlorite and Potassium Permanganate May Lead to Their Ineffectiveness Against Candida albicans
  28. Quantitative Analysis of Lactobionic Acid in Bioreactor Cultures and Selected Biological Activities
  29. Implementing the Design of Experiments (DoE) Concept into the Development of Mucoadhesive Tablets Containing Orange Peel Extract as a Potential Concept for the Treatment of Oral Infections
  30. Antimicrobial Dihydroflavonols and Isoflavans Isolated from the Root Bark of Dalbergia gloveri
  31. A brief overview of the medicinal and nutraceutical importance of Inonotus obliquus (chaga) mushrooms
  32. Plant Organic Acids as Natural Inhibitors of Foodborne Pathogens
  33. Corrigendum: The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: focus on the role of oxidative stress
  34. Electrospun Nanofibers with Pomegranate Peel Extract as a New Concept for Treating Oral Infections
  35. A comprehensive review on the health benefits, phytochemicals, and enzymatic constituents for potential therapeutic and industrial applications of Turkey tail mushrooms
  36. Unveiling the full spectrum of maitake mushrooms: A comprehensive review of their medicinal, therapeutic, nutraceutical, and cosmetic potential
  37. Electrospun Nanofibers Loaded with Marigold Extract Based on PVP/HPβCD and PCL/PVP Scaffolds for Wound Healing Applications
  38. Polish honeys exhibit activity against Pseudomonas aeruginosa isolated from wounds
  39. In Vitro Assessment of Antifungal and Antibiofilm Efficacy of Commercial Mouthwashes against Candida albicans
  40. Biological and clinical significance of the glypican-3 gene in human lung adenocarcinoma: An in silico analysis
  41. AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans
  42. Antimicrobial Activity of Psidium guajava Aqueous Extract against Sensitive and Resistant Bacterial Strains
  43. Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking
  44. Anti-Candida and Antibiofilm Activity of Selected Lamiaceae Essential Oils
  45. Synthesis of Selagibenzophenone A and Its Derivatives for Evaluation of Their Antiproliferative, RORγ Inverse Agonistic, and Antimicrobial Effect**
  46. Synthesis of silver complexes with chelating bidentate N‐heterocyclic ligands, their application in catalytic A3 coupling, and as antimicrobial agents
  47. In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever
  48. The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis
  49. The Phytochemistry of Ganoderma Species and their Medicinal Potentials
  50. The Effects of Propolis on Viral Respiratory Diseases
  51. Corrigendum: The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
  52. Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review
  53. Carcinogenic microbiota and its role in colorectal cancer development
  54. The oral microbiota and its role in carcinogenesis
  55. Nontoxic and Naturally Occurring Active Compounds as Potential Inhibitors of Biological Targets in Liriomyza trifolii
  56. The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
  57. In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19
  58. New Findings from Natural Substances
  59. High-Throughput Phototactic Ecotoxicity Biotests with Nauplii of Artemia franciscana
  60. Expression of ABCA1 Transporter and LXRA/LXRB Receptors in Placenta of Women with Late Onset Preeclampsia
  61. Effects of TIMP1 rs4898 Gene Polymorphism on Early-Onset Preeclampsia Development and Placenta Weight
  62. Bromination of eudesmin isolated from araucaria araucana induces epimerization and give bromine derivatives with loss of anti-Candida activity
  63. Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches
  64. Microbiota medicine: towards clinical revolution
  65. Antifungal Properties of Chemically Defined Propolis from Various Geographical Regions
  66. Curcuma longa L. Prevents the Loss of β-Tubulin in the Brain and Maintains Healthy Aging in Drosophila melanogaster
  67. What Do We Know about Antimicrobial Activity of Astaxanthin and Fucoxanthin?
  68. Placental mRNA and Protein Expression of VDR, CYP27B1 and CYP2R1 Genes Related to Vitamin D Metabolism in Preeclamptic Women
  69. Wound Antiseptics and European Guidelines for Antiseptic Application in Wound Treatment
  70. Evidence is insufficient to suggest that probiotics may reduce the risk of oral cancer
  71. Nanoparticles for Cancer Therapy: Current Progress and Challenges
  72. The Phenotypic Reactivity of Passiflora incarnata L. on Various Content of Mineral Salts and Regulators during Micropropagation and Acclimatization
  73. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2
  74. Live-Cell Systems in Real-Time Biomonitoring of Water Pollution: Practical Considerations and Future Perspectives
  75. Development and Evaluation of Thermosensitive Hydrogels with Binary Mixture of Scutellariae baicalensis radix Extract and Chitosan for Periodontal Diseases Treatment
  76. The Significance of VDR Genetic Polymorphisms in the Etiology of Preeclampsia in Pregnant Polish Women
  77. Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers
  78. Spike Protein Recognizer Receptor ACE2 Targeted Identification of Potential Natural Antiviral Drug Candidates Against SARS-CoV-2
  79. In silico studies of selected xanthophylls as potential candidates against SARS-CoV-2 targeting main protease (Mpro) and papain-like protease (PLpro)
  80. Toll-Like Receptors: General Molecular and Structural Biology
  81. Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer
  82. Plant Preparations and Compounds with Activities against Biofilms Formed by Candida spp.
  83. Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
  84. Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community
  85. Plant Phenolics and Extracts in Animal Models of Preeclampsia and Clinical Trials—Review of Perspectives for Novel Therapies
  86. Combined Effects of Methyldopa and Flavonoids on the Expression of Selected Factors Related to Inflammatory Processes and Vascular Diseases in Human Placenta Cells—An In Vitro Study
  87. Vitamin D receptor gene polymorphisms and haplotypes in the etiology of recurrent miscarriages
  88. The 2020 race towards SARS-CoV-2 specific vaccines
  89. Radioprotective Effects of Plants from the Lamiaceae Family
  90. Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity
  91. Development of tantalum with highly hydrophilic surface and antimicrobial properties obtained by micro‐arc oxidation process
  92. Transporter Associated with Antigen Processing 1 (TAP1) as a Potential Biomarker for Breast, Lung, Liver and Ovarian Cancer using Health Informatics
  93. The Role of Oral Microbiota in Intra-Oral Halitosis
  94. Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity
  95. Metallo-ß-lactamases: a review
  96. SARS-CoV, MERS-CoV, SARS-CoV-2 Comparison of Three Emerging Coronaviruses
  97. What do we know about SARS-CoV-2 virus and COVID-19 disease?
  98. Extracts and Flavonoids of Passiflora Species as Promising Anti-inflammatory and Antioxidant Substances
  99. Editorial: Antimicrobials and Anticancers of Bacterial Origins
  100. Essential Oils of Lamiaceae Family Plants as Antifungals
  101. The antimicrobial effectiveness of antiseptics as a challenge in hard to heal wounds
  102. Wytyczne postępowania miejscowego w ranach niezakażonych, zagrożonych infekcją oraz zakażonych – przegląd dostępnych substancji przeciwdrobnoustrojowych stosowanych w leczeniu ran. Zalecenia Polskiego Towarzystwa Leczenia Ran
  103. Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed in Plants
  104. The Microbiota and Pancreatic Cancer
  105. Fucoxanthin—An Antibacterial Carotenoid
  106. Antibacterial Properties of Propolis
  107. Snapshot of Phylogenetic Groups, Virulence, and Resistance Markers in Escherichia coli Uropathogenic Strains Isolated from Outpatients with Urinary Tract Infections in Bucharest, Romania
  108. Marine Macrolides with Antibacterial and/or Antifungal Activity
  109. New distributional data on bryophytes of Poland and Slovakia, 14
  110. Role of Oral Microbiota in Cancer Development
  111. Selected Medicines Used in Iontophoresis
  112. Anticancer Activity of Bacterial Proteins and Peptides
  113. Antibacterial activity of ethanolic extracts of some moss species
  114. Selected Factors of Innate Immunity in Healthy Individuals with S. aureus Nasal Carriage
  115. Expression of cagA, virB/D Complex and/or vacA Genes in Helicobacter pylori Strains Originating from Patients with Gastric Diseases
  116. Bacteriocins
  117. The Participation of p53 and bcl-2 Proteins in Gastric Carcinomas Associated with Helicobacter pylori and/or Epstein-Barr Virus (EBV)
  118. Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland
  119. Role of hand hygiene among healthcare personel
  120. Effect of novobiocin on the viability of human gingival fibroblasts (HGF-1)
  121. Effect of Oral Administration Involving a Probiotic Strain of Lactobacillus reuteri on Pro-Inflammatory Cytokine Response in Patients with Chronic Periodontitis
  122. Occurrence of Chlamydia trachomatis infections in infertile women in Poland
  123. Anticancer peptides from bacteria
  124. Cytokine Response in Autovaccine-Treated Patients with Chronic Staphylococcus Aureus Infections
  125. Bacillus oleronius and Demodex mite infestation in patients with chronic blepharitis
  126. Cytokine response in patients with chronic infections caused by Staphylococcus aureus strains and diversification of their Agr system classes
  127. Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-β1) in Patients with Gastric Cancer
  128. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients